MOLECULAR EXPRESS, INC.

Organization

AMES, IA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for substance use disorder vaccine formula...
- Patent number 11,739,054
- Issue date Aug 29, 2023
- MOLECULAR EXPRESS, INC.
- Kim Janda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for liposomal formulation of antigens and...
- Patent number 10,369,229
- Issue date Aug 6, 2019
- The Regents of the University of California
- Gary Fujii
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for liposomal formulation of antigens and...
- Patent number 9,931,419
- Issue date Apr 3, 2018
- Molecular Express, Inc.
- Gary Fujii
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for liposomal formulation of antigens and...
- Patent number 9,364,563
- Issue date Jun 14, 2016
- The Regents of the University of California
- Gary Fujii
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for liposomal formulation of antigens and...
- Patent number 8,765,171
- Issue date Jul 1, 2014
- The Regents of the University of California
- Gary Fujii
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULA...
- Publication number 20210107862
- Publication date Apr 15, 2021
- MOLECULAR EXPRESS, INC.
- Kim JANDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULA...
- Publication number 20200115324
- Publication date Apr 16, 2020
- MOLECULAR EXPRESS, INC.
- Kim JANDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND...
- Publication number 20180280534
- Publication date Oct 4, 2018
- The Regents of the University of California
- Gary FUJII
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND...
- Publication number 20170157266
- Publication date Jun 8, 2017
- MOLECULAR EXPRESS, INC.
- Gary FUJII
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPOSOMAL FORMULATIONS
- Publication number 20140287022
- Publication date Sep 25, 2014
- MOLECULAR EXPRESS, INC.
- Gary Fujii
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
78768853 - MOLECULAR GPS
- Serial number 78768853
- Registration number 3459477
- Filing date Dec 7, 2005
- Molecular Express, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75644136 - MIMIPATH
- Serial number 75644136
- Filing date Feb 19, 1999
- Molecular Express, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75644067 - VESIVAX
- Serial number 75644067
- Registration number 2498737
- Filing date Feb 19, 1999
- Molecular Express, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
75644060 - MOLECULAR EXPRESS, INC.
- Serial number 75644060
- Registration number 2530262
- Filing date Feb 19, 1999
- Molecular Express, Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 30

Research Projects

Information Research Project
Non-clinical Development of a Synthetic Lung Surfactant for Treatme...
- Application id 10252528
- Award notice date Jun 16, 2021
Information Research Project
Development of a Vaccine for the Prevention of Pulmonary Aspergillosis
- Application id 9517700
- Award notice date Jun 26, 2018
Information Research Project
The VesiVax® System: Vaccine Development Made Easy
- Application id 9319126
- Award notice date Jul 14, 2017
Information Research Project
Development of a Vaccine for the Prevention of Pulmonary Aspergillosis
- Application id 9408410
- Award notice date Jun 28, 2017
Information Research Project
VesiVax® Peanut Allergy Immunotherapy
- Application id 9345535
- Award notice date Feb 7, 2017
Information Research Project
Pre-clinical Development of a Vaccine for the Treatment of Heroin A...
- Application id 9322037
- Award notice date Jul 29, 2016
Information Research Project
The VesiVax® System: Vaccine Development Made Easy
- Application id 9141409
- Award notice date Jul 20, 2016
Information Research Project
Optimization of VesiVax® Lipidated Tucaresol Formulations
- Application id 9131908
- Award notice date Mar 15, 2016
Information Research Project
Pre-clinical Development of a Vaccine for the Treatment of Heroin A...
- Application id 8981051
- Award notice date Sep 1, 2015
Information Research Project
Development of a Gene and Oligonucleotide Delivery System
- Application id 8981573
- Award notice date Aug 20, 2015
Information Research Project
Development of a Vaccine for the Prevention of Pulmonary Aspergillosis
- Application id 8977244
- Award notice date Jun 15, 2015
Information Research Project
Design and Engineering of Nanoparticulate Universal Vaccines
- Application id 8978668
- Award notice date Jun 10, 2015
Information Research Project
Development of a novel SP-B peptide lung surfactant
- Application id 8704985
- Award notice date Aug 16, 2014
Information Research Project
Novel VLP Adjuvant based on the VesiVax system
- Application id 8720689
- Award notice date Jul 17, 2014
Information Research Project
Engineering of a Novel CDN Nanoparticle Platform
- Application id 8782396
- Award notice date Jun 19, 2014
Information Research Project
Novel VLP Adjuvant based on the VesiVax system
- Application id 8524930
- Award notice date Aug 13, 2013
Information Research Project
Development of a novel SP-B peptide lung surfactant
- Application id 8532016
- Award notice date Jul 22, 2013
Information Research Project
Development of VesiVax Carbohydrate Conjugation Chemistry
- Application id 8593016
- Award notice date Jul 19, 2013
Information Research Project
Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Li...
- Application id 8512653
- Award notice date Jul 17, 2013
Information Research Project
Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes
- Application id 8432792
- Award notice date Feb 28, 2013
Information Research Project
Development of a novel SP-B peptide lung surfactant
- Application id 8314386
- Award notice date Aug 16, 2012
Information Research Project
Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Li...
- Application id 8251958
- Award notice date Jul 17, 2012
Information Research Project
Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes
- Application id 8252011
- Award notice date Feb 23, 2012
Information Research Project
Liposomal Nicotine Vaccine Development
- Application id 8211742
- Award notice date Jul 26, 2011
Information Research Project
Surrogate endpoints for correlating protective immunity in response...
- Application id 7924225
- Award notice date Aug 20, 2010
Information Research Project
Genital Herpes Vaccine Discovery
- Application id 8068125
- Award notice date May 11, 2010
Information Research Project
Surrogate endpoints for correlating protective immunity in response...
- Application id 7608534
- Award notice date Aug 31, 2009
Information Research Project
Aptamers for Imaging and Therapy
- Application id 7673662
- Award notice date Aug 31, 2009
Information Research Project
Virus Electrodes for Fungal Pathogen Detection
- Application id 7676716
- Award notice date Aug 12, 2009
Information Research Project
Genital Herpes Vaccine Discovery
- Application id 7640741
- Award notice date Jul 14, 2009

MOLECULAR EXPRESS, INC.

Organization

Patents Grantslast 30 patents

Methods and compositions for substance use disorder vaccine formula...

Methods and compositions for liposomal formulation of antigens and...

Methods and compositions for liposomal formulation of antigens and...

Methods and compositions for liposomal formulation of antigens and...

Methods and compositions for liposomal formulation of antigens and...

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULA...

METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULA...

METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND...

METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND...

LIPOSOMAL FORMULATIONS

Trademarklast 30 trademarks

78768853 - MOLECULAR GPS

75644136 - MIMIPATH

75644067 - VESIVAX

75644060 - MOLECULAR EXPRESS, INC.

NIH Research Projectlast 12 months

Research Projects

Non-clinical Development of a Synthetic Lung Surfactant for Treatme...

Development of a Vaccine for the Prevention of Pulmonary Aspergillosis

The VesiVax&#174; System: Vaccine Development Made Easy

Development of a Vaccine for the Prevention of Pulmonary Aspergillosis

VesiVax&#174; Peanut Allergy Immunotherapy

Pre-clinical Development of a Vaccine for the Treatment of Heroin A...

The VesiVax&#174; System: Vaccine Development Made Easy

Optimization of VesiVax&#174; Lipidated Tucaresol Formulations

Pre-clinical Development of a Vaccine for the Treatment of Heroin A...

Development of a Gene and Oligonucleotide Delivery System

Development of a Vaccine for the Prevention of Pulmonary Aspergillosis

Design and Engineering of Nanoparticulate Universal Vaccines

Development of a novel SP-B peptide lung surfactant

Novel VLP Adjuvant based on the VesiVax system

Engineering of a Novel CDN Nanoparticle Platform

Novel VLP Adjuvant based on the VesiVax system

Development of a novel SP-B peptide lung surfactant

Development of VesiVax Carbohydrate Conjugation Chemistry

Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Li...

Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes

Development of a novel SP-B peptide lung surfactant

Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Li...

Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes

Liposomal Nicotine Vaccine Development

Surrogate endpoints for correlating protective immunity in response...

Genital Herpes Vaccine Discovery

Surrogate endpoints for correlating protective immunity in response...

Aptamers for Imaging and Therapy

Virus Electrodes for Fungal Pathogen Detection

Genital Herpes Vaccine Discovery

The VesiVax® System: Vaccine Development Made Easy

VesiVax® Peanut Allergy Immunotherapy

The VesiVax® System: Vaccine Development Made Easy

Optimization of VesiVax® Lipidated Tucaresol Formulations